SCHEMBL26239252

SCHEMBL26239252

COC(=O)c1cc(NS(C)(=O)=O)ccc1OCCN(C)CCc1ccc(C)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.59
CACNA1F O60840 1/20 0.57
CHRM2 P08172 1/20 0.57
ACHE P22303 1/20 0.57
AGTR1 P30556 1/20 0.57
DRD3 P35462 1/20 0.57
CACNA1D Q01668 1/20 0.57
CACNA1S Q13698 1/20 0.57
CACNA1C Q13936 1/20 0.57
CHEK1 O14757 1/20 0.45
AURKA O14965 1/20 0.45
DAPK3 O43293 1/20 0.45
JAK2 O60674 1/20 0.45
ABL1 P00519 1/20 0.45
NTRK1 P04629 1/20 0.45
FYN P06241 1/20 0.45
CSF1R P07333 1/20 0.45
RET P07949 1/20 0.45
IGF1R P08069 1/20 0.45
MET P08581 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26240045 0.95 KCNH2 (0.64) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL26240154 0.82 KCNH2 (0.57) KCNH2CACNA1FCHRM2ACHEAGTR1
Hydrochloric Acid SCHEMBL6575851 0.81 KCNH2 (0.73) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL26240216 0.78 KCNH2 (0.52) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL6574115 0.77 KCNH2 (0.84) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL24600583 0.77 KCNH2 (0.46) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL10725452 0.77 KCNH2 (0.64) KCNH2CACNA1FCHRM2ACHEAGTR1
Hydrochloric Acid SCHEMBL6573588 0.76 KCNH2 (0.78) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL8420350 0.75 CHEK1 (0.48) KCNH2CACNA1FCHRM2ACHEAGTR1
Hydrochloric Acid SCHEMBL6574061 0.75 KCNH2 (0.77) KCNH2CACNA1FCHRM2ACHEAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025846-A1 ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS ACAD PHARMACEUTICALS INC (US) 2024-01-25 US disclosed
US-11731938-B2 Ultra short acting anti-arrhythmic agents ACADEMIC PHARMACEUTICALS INC (US) 2023-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11731938-B2 Ultra short acting anti-arrhythmic agents CACNA1G, SCN5A, CACNA1F KCNH2 51/4885CACNA1F 3/4885CHRM2 1597/4885
US-20240025846-A1 ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS CACNA1G, SCN5A, CACNA1F KCNH2 51/4885CACNA1F 3/4885CHRM2 1597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.